Repligen
RGEN
#1860
Rank
ยฃ8.29 B
Marketcap
ยฃ129.73
Share price
2.97%
Change (1 day)
17.15%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of June 2026 : ยฃ2.20 Billion

According to Repligen 's latest financial reports the company's total assets are ยฃ2.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ2.21 B6.24%
2022-12-31ยฃ2.08 B19.44%
2021-12-31ยฃ1.74 B25.15%
2020-12-31ยฃ1.39 B30.75%
2019-12-31ยฃ1.06 B74.97%
2018-12-31ยฃ0.61 B10.93%
2017-12-31ยฃ0.55 B134.96%
2016-12-31ยฃ0.23 B137.28%
2015-12-31ยฃ98.68 M19.75%
2014-12-31ยฃ82.4 M14.56%
2013-12-31ยฃ71.92 M19.84%
2012-12-31ยฃ60.02 M
2011-03-31ยฃ45.08 M-3.46%
2010-03-31ยฃ46.7 M-8.43%
2009-03-31ยฃ51 M48.83%
2008-03-31ยฃ34.26 M131.32%
2007-03-31ยฃ14.81 M-10.47%
2006-03-31ยฃ16.54 M12.93%
2005-03-31ยฃ14.65 M-8.14%
2004-03-31ยฃ15.95 M-6.15%
2003-03-31ยฃ16.99 M-16.79%
2002-03-31ยฃ20.42 M-10.09%
2001-03-31ยฃ22.71 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ150.40 B 6,717.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ84.63 B 3,736.17%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ95.11 B 4,211.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ66.38 B 2,909.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ44.84 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.71 B-67.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ4.00 B 81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ1.93 B-12.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ8.76 B 297.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ5.63 B 155.31%๐Ÿ‡บ๐Ÿ‡ธ USA